[Glucocorticoid for coronavirus disease 2019: a dilemma].
作者信息
Du Xinxin, Yu Xiangyou
机构信息
Department of Critical Care Medicine, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China. Corresponding author: Yu Xiangyou, Email:
出版信息
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):278. doi: 10.3760/cma.j.cn121430-20200309-00352.
Abstract
摘要
相似文献
1
[Glucocorticoid for coronavirus disease 2019: a dilemma].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):278. doi: 10.3760/cma.j.cn121430-20200309-00352.
2
Orthopaedic Considerations Following COVID-19: Lessons from the 2003 SARS Outbreak.
JBJS Rev. 2020 Jul;8(7):e2000052. doi: 10.2106/JBJS.RVW.20.00052.
3
What can we learn about corticosteroid therapy as a treatment for COVID-19?
Osteoporos Int. 2020 Aug;31(8):1595. doi: 10.1007/s00198-020-05487-w. Epub 2020 Jun 9.
4
[Not Available].
Rev Med Suisse. 2020 Apr 29;16(N° 691-2):876-877.
5
Meta-analysis of Effect of Statins in Patients with COVID-19.
Am J Cardiol. 2020 Nov 1;134:153-155. doi: 10.1016/j.amjcard.2020.08.004. Epub 2020 Aug 12.
6
[Not Available].
Rev Med Suisse. 2020 Jun 17;16(698):1272-1273.
7
[Not Available].
Rev Med Suisse. 2020 Apr 15;16(690):756-757.
8
Cancer did not stay home for COVID-19.
Sci Adv. 2020 Sep 11;6(37). doi: 10.1126/sciadv.abd7487. Print 2020 Sep.
9
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
Pan Afr Med J. 2020 Sep 10;37:47. doi: 10.11604/pamj.2020.37.47.24200. eCollection 2020.
10
[Not Available].
Rev Med Suisse. 2020 Jun 10;16(697):1218-1219.
Zotero 插件